
ICON Public Company Investor Relations Material
Latest events

Q2 2025
ICON Public Company
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from ICON Public Limited Company
Access all reports
ICON Public Limited Company is a global provider of clinical research and development services to the pharmaceutical, biotechnology, and medical device industries. The company offers a broad range of outsourced services, including clinical trial management, data analytics, regulatory support, and laboratory services. ICON works with clients to facilitate the development and approval of new medical treatments and therapies, supporting clinical trials from early-phase research through to post-market studies. The company's expertise spans multiple therapeutic areas and geographies. The company is headquartered in Dublin, Ireland, and its shares are listed on the NASDAQ.
Key slides for ICON Public Limited Company


Q2 2025
ICON Public Limited Company


43rd Annual J.P. Morgan Healthcare Conference 2025
ICON Public Limited Company
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
ICLR
Country
🇺🇸 United States